• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Study supports use of CamDiab artificial pancreas in pregnant women with type 1 diabetes

July 5, 2023 By Sean Whooley

CamDiab CamAPS FX
The CamAPS FX app. [Image from CamDiab]
The CamDiab CamAPS FX automated insulin delivery (AID) system produced better outcomes for pregnant women with type 1 diabetes in a clinical study.

Medscape reported that data came from the largest randomized controlled trial pitting an AID system against standard insulin delivery in pregnant women with type 1 diabetes. The automated CamAPS FX came out on top. Percentage time spent in the pregnancy-specific target blood glucose range from 16 weeks gestation to delivery proved significantly higher. That range totaled 63-140 mg/dL (3.5-7.8 mmol/L).

Dr. Helen Murphy presented the findings in an e-poster session at the American Diabetes Association (ADA) 83rd Scientific Sessions. She said the hybrid closed-loop system demonstrated improved maternal glucose and stated all pregnant women with type 1 diabetes should have access. Murphy serves as a professor of medicine at the University of East Anglia and a clinician at Norfolk and Norwich University Hospital in the UK.

More about the CamDiab CamAPS FX platform

CamAPS FX is the only AID system approved in Europe and the UK for type 1 diabetes from age one and during pregnancy. It features integration capabilities with the Dexcom G6 and worked in tandem with the continuous glucose monitor in this study.

The platform also integrates with the FreeStyle Libre 3 — Abbott’s newest sensor — to work with the Ypsomed mylife YpsoPump. It remains unavailable in the U.S.

According to Medscape, researchers think the findings offer evidence for the UK National Institute of Clinical Excellence (NICE) to recommend that all pregnant women with type 1 diabetes should have access to the CamAPS-FX system. Murphy said researchers require more data on glucose profiles to consider extending the technology to type 2 diabetes in pregnancy.

 

This article previously referenced the CamDiab platform’s integration with the Abbott FreeStyle Libre 3. The system also integrates with the Dexcom G6 and the study referenced in the article used that sensor. This article was updated to reflect this.

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Pain Management, Technology Tagged With: CamDiab

IN CASE YOU MISSED IT

  • Omnipod 5 rollout for type 2 rolls on as Insulet pursues next-gen automation
  • LifePlus reports clinical validation of non-invasive glucose, blood pressure monitor
  • Abbott Diabetes head talks Medtronic partnership, exciting times ahead
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS